We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Government Joins Lawsuit Over Rapumune Off-Label Marketing
Government Joins Lawsuit Over Rapumune Off-Label Marketing
October 22, 2010
The U.S. government has won approval from a federal court to join a whistleblower lawsuit accusing Wyeth of marketing its drug Rapamune for off-label uses and providing doctors with kickbacks to prescribe it.